Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest

This study is not yet open for participant recruitment.

Verified by Charite University, Berlin, Germany, May 2007

Sponsored by:	Charite University, Berlin, Germany
Information provided by:	Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:	NCT00472147

Purpose

Sudden cardiac death is the most frequent cause of death in industrialized countries. The most efficient interventiont in ventricular fibrillation is defibrillation in an appropriate timely manner. But since the intervention of defibrillation the optimal shock energy is unknown. As a too low energy is not able to terminate ventricular fibrillation a too high energy may cause asystole wich jeopardizes survival itself. We study the efficacy of different shock energies on the termination of ventricular fibrillatiion and survival.

Condition	Intervention
Sudden Cardiac Death Arrhythmia Survival	Procedure: shock efficacy

Genetics Home Reference related topics: Brugada syndrome short QT syndrome

MedlinePlus related topics: Arrhythmia Cardiac Arrest

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:

termination of vf survival

Secondary Outcome Measures:

resulting rhythm CPC score

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

out of hospital sudden cardiac death
ventricular fibrillation

Exclusion Criteria:

non cardiac death
asystole

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472147

Contacts

Contact: Dirk Müller, MD, PhD	+49 30 8445 ext 3554	dr.dirk.mueller@charite.de
Contact: Hans-Richard Arntz, MD, PhD	+49 30 8445 ext 2640	hans-richard.arntz@charite.de

Locations

Germany
Charité campus Benjamin Franklin
Berlin, Germany, 12200

Sponsors and Collaborators

Charite University, Berlin, Germany

Investigators

Principal Investigator:

Dirk Müller, MD, PhD

Charité, Campus Benjamin Franklin

More Information

Study ID Numbers:	CBF-2007002
Study First Received:	May 10, 2007
Last Updated:	May 10, 2007
ClinicalTrials.gov Identifier:	NCT00472147
Health Authority:	Germany: Federal Institute for Drugs and Medical Devices

Study placed in the following topic categories:

Death
Heart Diseases
Shock
Death, Sudden

Heart Arrest
Death, Sudden, Cardiac
Arrhythmias, Cardiac

Additional relevant MeSH terms:

Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009